Mindray Medical (MR) Misses Q4 EPS by 2c, Revenue Falls Short, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Mindray Announces 2014 Fourth Quarter and Full Year Results
March 9, 2015 5:00 PM EDTSHENZHEN, China, March 9, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2014.
Highlights for Fourth Quarter and Full Year 2014
Full year net revenues increased 9.0% year-over-year to $1.3 billion. China net revenues rose 10.1% to $606.7 million for the full year. International sales reached $716.1 million, representing an 8.0% increase from a year ago. In the fourth quarter, China net revenues increased 13.9%... More